Isocitrate Dehydrogenase Mutation in \u3ci\u3eVibrio anguillarum\u3c/i\u3e Results in Virulence Attenuation and Immunoprotection in Rainbow Trout (\u3ci\u3eOncorhynchus mykiss\u3c/i\u3e) by Mou, Xiangyu et al.
University of Rhode Island
DigitalCommons@URI
Cell and Molecular Biology Faculty Publications Cell and Molecular Biology
2017
Isocitrate Dehydrogenase Mutation in Vibrio
anguillarum Results in Virulence Attenuation and
Immunoprotection in Rainbow Trout
(Oncorhynchus mykiss)
Xiangyu Mou
University of Rhode Island
Edward J. Spinard
University of Rhode Island
See next page for additional authors
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Follow this and additional works at: https://digitalcommons.uri.edu/cmb_facpubs
This Article is brought to you for free and open access by the Cell and Molecular Biology at DigitalCommons@URI. It has been accepted for inclusion
in Cell and Molecular Biology Faculty Publications by an authorized administrator of DigitalCommons@URI. For more information, please contact
digitalcommons@etal.uri.edu.
Citation/Publisher Attribution
Mou, X., Spinard, E. J., Hillman, S. L., & Nelson, D. R. Isocitrate dehydrogenase mutation in Vibrio anguillarum results in virulence
attenuation and immunoprotection in rainbow trout (Oncorhynchus mykiss). (2017) BMC microbiology, 17(1), 217. doi:10.1186/
s12866-017-1124-1
Available at: http://dx.doi.org/10.1186/s12866-017-1124-1
Authors
Xiangyu Mou, Edward J. Spinard, Shelby L. Hillman, and David R. Nelson
This article is available at DigitalCommons@URI: https://digitalcommons.uri.edu/cmb_facpubs/79
RESEARCH ARTICLE Open Access
Isocitrate dehydrogenase mutation in Vibrio
anguillarum results in virulence attenuation
and immunoprotection in rainbow trout
(Oncorhynchus mykiss)
Xiangyu Mou1,2†, Edward J. Spinard1†, Shelby L. Hillman1 and David R. Nelson1*
Abstract
Background: Vibrio anguillarum is an extracellular bacterial pathogen that is a causative agent of vibriosis in finfish
and crustaceans with mortality rates ranging from 30% to 100%. Mutations in central metabolism (glycolysis and the
TCA cycle) of intracellular pathogens often result in attenuated virulence due to depletion of required metabolic
intermediates; however, it was not known whether mutations in central metabolism would affect virulence in an
extracellular pathogen such as V. anguillarum.
Results: Seven central metabolism mutants were created and characterized with regard to growth in minimal
and complex media, expression of virulence genes, and virulence in juvenile rainbow trout (Oncorhynchus
mykiss). Only the isocitrate dehydrogenase (icd) mutant was attenuated in virulence against rainbow trout
challenged by either intraperitoneal injection or immersion. Further, the icd mutant was shown to be
immunoprotective against wild type V. anguillarum infection. There was no significant decrease in the
expression of the three hemolysin genes detected by qRT-PCR. Additionally, only the icd mutant exhibited a
significantly decreased growth yield in complex media. Growth yield was directly related to the abundance of
glutamate. A strain with a restored wild type icd gene was created and shown to restore growth to a wild
type cell density in complex media and pathogenicity in rainbow trout.
Conclusions: The data strongly suggest that a decreased growth yield, resulting from the inability to
synthesize α-ketoglutarate, caused the attenuation despite normal levels of expression of virulence genes.
Therefore, the ability of an extracellular pathogen to cause disease is dependent upon the availability of host-
supplied nutrients for growth. Additionally, a live vaccine strain could be created from an icd deletion strain.
Keywords: Vibrio anguillarum, TCA cycle, Vibriosis, Isocitrate dehydrogenase, Virulence, Hemolysin
Background
The aquaculture industry now produces half of all fish
intended for human consumption and employs millions
of people worldwide [1]. Although the first value sale of
harvested fish has increased by 267% between 2004 and
2014 to over US$160 billion, infectious diseases,
especially those caused by Vibrio spp. including Vibrio
anguillarum, still represent a major impediment to the
production of fish [1]. V. anguillarum causes diseases in
crustaceans and bivalves, and is the leading causative
agent of vibriosis in finfish including salmon, rainbow
trout, turbot, sea bass, sea bream, cod, eel, and ayu [2].
Infections by this bacterial species have resulted in se-
vere economic losses to aquaculture industries world-
wide [3].
V. anguillarum is an extracellular pathogen that
invades its host fish through the intestine, skin or gills
[4, 5]. Systemic infection by V. anguillarum usually
causes fish to die within 1–4 days [6–9]. Chemotactic
motility and the metalloprotease EmpA have been
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shown to be important virulence factors during the inva-
sion stage while the siderophore anguibactin, flagellin
subunits and lipopolysaccharides were shown to be im-
portant for persistence in the host during the post-
invasion stage [2, 10]. Three secreted proteins that are
cytotoxic against epithelial cells and erythrocytes have
been characterized in V. anguillarum: the HlyA homolog
Vah1, the phospholipase Plp, and the MARTX toxin
RtxA [7, 9, 11]. Mutations in vah1 and/or plp resulted
in slight attenuation against juvenile Atlantic salmon
(Salmo salar); however, rtxA mutants were avirulent
[7, 9, 11]. Additionally, a V. anguillarum mutant that
lacks H-NS, a global transcriptional regulator that re-
presses the transcription of vah1, plp, and rtxA,
showed attenuation in virulence when injected intra-
peritoneally, suggesting that proper coordination of
gene expression is an important factor during the
post-invasion stage [8].
Since the 1980s, several bacterial species that are
auxotrophic for aromatic compounds have been shown
to be avirulent [12–16]. More recently, mutants that are
hypothesized to experience growth defects in the nutri-
ent limited environment inside a phagocyte have been
characterized. In Salmonella enterica, an intracellular
bacterial pathogen, some tricarboxylic acid (TCA) cycle
mutant strains were avirulent and immunoprotective for
subsequent wild-type S. enterica infection [17–21]. A
functional fructose repressor (Cra) was also required for
S. enterica infection [22]. Similar results have been
observed for central metabolism mutants in other intra-
cellular pathogens such as uropathogenic Escherichia
coli (UPEC), Mycobacterium tuberculosis, and the facul-
tative intracellular fish pathogen Edwardsiella ictaluri
[23–27]. These observations demonstrate that central
metabolism is important for pathogenesis by intracellu-
lar pathogens.
Accordingly, we hypothesized that mutations in cen-
tral metabolism could interrupt the infection process
of V. anguillarum in juvenile rainbow trout (Onco-
rhynchus mykiss). In this study, we identified and cre-
ated six TCA cycle mutant strains plus one fructose
metabolism mutant strain, and tested their virulence
against juvenile rainbow trout using two infection
methods, intraperitoneal (IP) injection and immersion.
Further, the expression of each of the three hemolysin
genes (vah1, plp, and rtxA) was examined to deter-
mine whether attenuation resulted from decreased
virulence factor expression in these mutants. The
growth rates and yield of each mutant strain in com-
plex media were also determined. We specifically
characterized the growth defect of the attenuated icd
mutant. We also created, tested, and compared a re-
stored wild type icd strain for virulence and growth
to both the wild type and the icd mutant.
Methods
Bacterial strains, plasmids and growth conditions
V. anguillarum strains (Table 1) were routinely grown in
Lysogeny broth containing 2% NaCl (LB20) [28] or
Marine Minimum Median (3M) + 0.15% glucose [29],
supplemented with the appropriate antibiotic, in a shak-
ing water bath at 27 °C. E. coli strains (Table 1) were
routinely grown in Lysogeny broth containing 1% NaCl
(LB10) supplemented with the appropriate antibiotic, in
a shaking water bath at 37 °C. Antibiotics were used at
the following concentrations: streptomycin, 200 μg/ml
(Sm200); chloramphenicol, 20 μg/ml (Cm20) for E. coli
and 5 μg/ml (Cm5) for V. anguillarum; kanamycin, 50
μg/ml (Km50) for E. coli and 80 μg/ml (Km80) for V.
anguillarum.
Identification of genes in V. anguillarum
V. anguillarum M93Sm draft genome (accession number
NOWD00000000) was annotated by the RAST (Rapid
Annotation using Subsystem Technology) service (http://
rast.nmpdr.org/rast.cgi) using the default settings [30].
The following annotated genomes were downloaded from
NCBI: V. anguillarum 775 (accession numbers: NC_015
633.1 and NC_015637.1), 96F (accession number: NZ_AE
ZA00000000.1), M3 (accession numbers: NC_022223.1,
NC_022224.1 and NC_022225.1), NB10 (accession num-
bers: NZ_LK021130.1, NZ_LK021129.1 and NZ_LK0
21128.1), RV22 (accession number: AEZB00000000.1) and
90–11-286 (accession numbers: NZ_CP011460.1 and
NZ_CP011461.1).
Insertional mutagenesis
Insertional mutations were made by using a modification
of the procedure described by Milton et al. [31]. Briefly,
primers (Table 2) were designed based on the target
gene sequence of M93Sm. An internal 200–300 bp DNA
fragment of the first third of the target gene was PCR
amplified and ligated into the suicide vector pNQ705–1
(Table 1) after digestion with SacI and XbaI. The ligation
mixture was introduced into E. coli SM10 by electropor-
ation using a BioRad Gene Pulser II (BioRad, Hercules,
CA). Transformants were selected on LB10 Cm20 agar
plates. The construction of the recombinant pNQ705
was confirmed by both PCR amplification and restriction
enzyme analysis. The mobilizable suicide vector was
transferred from E. coli SM10 into V. anguillarum by
conjugation [32]. Transconjugants were selected by util-
izing the chloramphenicol resistance gene located on the
suicide plasmid. The incorporation of the recombinant
pNQ705 was confirmed by PCR amplification.
Fish infection experiments
Various V. anguillarum strains were tested for virulence
against rainbow trout (O. mykiss) by intraperitoneal (IP)
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injection or immersion. Briefly, V. anguillarum cells
grown for 19 h at 27 °C in LB20 supplemented with the
appropriate antibiotics were harvested by centrifugation
(9000×g, 5 min, 4 °C), washed twice in nine salts solu-
tion (NSS), and resuspended in NSS [33, 34]. Aliquots
(100 μl) of the V. anguillarum NSS suspension were
used to determine the OD600. The V. anguillarum NSS
suspension was prepared to the desired specific cell
density according to the conversion equation as
determined by experimentation (data not shown): Cell
density (108 CFU/ml) = 44.905 × OD600. The actual cell
density of the suspension was confirmed by dilution and
viable plate count. All fish were examined and deter-
mined to be disease and injury free prior to the start of
each experiment. For IP injection, fish were anesthetized
by tricaine methanesulfonate (Western Chemical,
Ferndale, WA), (100 mg/l for induction and 52.5 mg/l
for maintenance). V. anguillarum strains were IP
injected into fish that were between 15 and 25 cm long
in a 100 μl NSS vehicle at a dose of either 2 × 105 or 4 ×
105 CFU/fish, or with NSS only as a negative control.
For immersion, 10 ml of V. anguillarum suspended in
NSS, or 10 ml of NSS only as a negative control was
added to a bucket filled with 10 L of water supple-
mented with 1.5% NaCl that was maintained at 18 ±
1 °C. Fish that were between 15 and 25 cm long were
added and immersed for 1 h. For both methods, fish
inoculated with different bacterial strains were main-
tained in separate 10-gal (38 L) tanks to prevent pos-
sible cross-contamination with constant water flow
(200 ml/min) at 18 ± 1 °C. Death due to vibriosis was
determined by the observation of gross clinical symp-
toms and confirmed by the recovery and isolation of
V. anguillarum cells resistant to the appropriate anti-
biotics from the spleen or head kidney of dead fish.
Observations were made for 8–14 days. All fish used
in this research project were obtained from the URI
East Farm Aquaculture Center. All fish infection pro-
tocols were approved by the URI IACUC. (IACUC
Protocol AN06–08-002).
RNA isolation
Exponential phase cells (~0.5 × 108 CFU/ml) of various V.
anguillarum strains were treated with RNAprotect Bac-
teria Reagent (QIAGEN), following the manufacturer’s in-
structions. Total RNA was isolated using the RNeasy kit
and QIAcube (QIAGEN) following the instructions of the
manufacturer. All purified RNA samples were quantified
spectrophotometrically by measuring absorption at
260 nm and 280 nm using a NanoDrop ND-1000 spectro-
photometer (Thermo Fisher Scientific) and overall quality
was assessed by gel electrophoresis. Samples were stored
at −75 °C for future use.
Real-time quantitative RT-PCR (qRT-PCR)
qRT-PCR was used to quantify various mRNAs using an
LightCycler® 480 Real-Time PCR System (Hoffmann-La
Roche Inc.) and the Brilliant II SYBR Green Single-Step
QRT-PCR Master Mix (Agilent Technologies), with
10 ng of total RNA in 20 μl reaction mixtures. The ther-
mal profile was 50 °C for 30 min, 95 °C for 15 min, and
then 40 cycles of 95 °C for 30 s and 55 °C for 30 s.
Fluorescence was measured at the end of the 55 °C stage
Table 1 Bacterial strains and plasmids used in this study
Strain or plasmid Description Reference
V. anguillarum strains
M93Sm Spontaneous Smr mutant of M93
(serotype O2a)
[47]
XM420 Smr Cmr; icd insertional mutant This study
ES422 Smr; Restored icd strain This study
XM440 Smr Cmr; sucA insertional mutant This study
XM450 Smr Cmr; sucC insertional mutant This study
XM460 Smr Cmr; sdhC insertional mutant This study
XM470 Smr Cmr; fumA insertional mutant This study
XM410 Smr Cmr; mdh insertional mutant This study
XM430 Smr Cmr; cra insertional mutant This study
E. coli strains
SM10 thi thr leu tonA lacY supE recA
RP4–2-Tc::Mu::Km (λ pir)
[48]
S100 Kmr; Sm10 containing plasmid
pNQ705–1
[49]
Q420 Kmr Cmr; Sm10 containing
plasmid pNQ705-icd
This study
Q440 Kmr Cmr; Sm10 containing
plasmid pNQ705-sucA
This study
Q450 Kmr Cmr; Sm10 containing
plasmid pNQ705-sucC
This study
Q460 Kmr Cmr; Sm10 containing
plasmid pNQ705-sdhC
This study
Q470 Kmr Cmr; Sm10 containing
plasmid pNQ705-fumA
This study
Q410 Kmr Cmr; Sm10 containing
plasmid pNQ705-mdh
This study
Q430 Kmr Cmr; Sm10 containing
plasmid pNQ705-cra
This study
Plasmid
pNQ705–1 Cmr; suicide vector with R6K origin [49]
pNQ705-icd Cmr; For icd insertional mutant This study
pNQ705-sucA Cmr; For sucA insertional mutant This study
pNQ705-sucC Cmr; For sucC insertional mutant This study
pNQ705-sdhC Cmr; For sdhC insertional mutant This study
pNQ705-fumA Cmr; For fumA insertional mutant This study
pNQ705-mdh Cmr; For mdh insertional mutant This study
pNQ705-cra Cmr; For cra insertional mutant This study
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of each cycle. Samples were run in triplicate along with
the no-reverse-transcriptase control and the no-template
control. All experiments were repeated at least twice.
Growth experiments
To cultivate bacteria for growth experiments, V. angu-
illarum cells grown overnight at 27 °C in LB20
supplemented with the appropriate antibiotics were
harvested by centrifugation (9000×g, 2 min), washed
twice and resuspended in in NSS. A 200 μl aliquot of
the V. anguillarum NSS suspension was transferred
into a 96-well plate with a clear flat bottom and the
optical density at 600 nm (OD600) was read by a Ver-
saMax™ Absorbance Microplate Reader (Molecular
Devices). The V. anguillarum NSS suspension was
prepared to an OD600 of 0.420 (~4 × 10
7 CFU/ml) and
diluted 1:100 into fresh media. Growth was monitored
either by measurement of the OD600 or by serial dilu-
tion and plate counts.
Resolving the merodiploid in the icd mutant
V. anguillarum icd mutant cells grown in LB20 sup-
plemented with appropriate antibiotics for 19 h at
27 °C were harvested by centrifugation (9000×g,
2 min), washed three times in NSS, and resuspended
in NSS. Cell suspensions (100 μl) were spread onto
Marine Minimum Median (3 M) + 0.15% glucose agar.
Well-isolated colonies were picked and subsequently
streak purified onto a new 3 M+ 0.15% glucose agar. Iso-
lated colonies were then transferred to LB20Cm5 agar to
screen for chloramphenicol sensitivity. Resolution of the
merodiploid was confirmed by PCR amplification.
Statistical analysis
A Kaplan-Meier survival analysis with log rank signifi-
cance test was performed on the survival curves in the
fish infection experiment. Student’s T-tests assuming un-
equal variances were used for experiments containing
two data groups. One-way ANOVA with Tukey post hoc
test was performed for all other experiments. P values of
<0.05 were considered statistically significant.
Results
Identification and mutant construction of TCA cycle genes
in V. anguillarum
In order to identify gene targets for mutagenesis the
published genomes of V. anguillarum strains 775,
96F, M3, NB10, RV22, 90-11-286 and the V. anguil-
larum M93Sm draft genome (accession number
NOWD00000000) annotated by RAST were examined
and found to have the following TCA cycle genes/op-
erons: gltA, acnB, icd, sucAB, sucCD, sdhCDAB,
Table 2 Primers used in this study
Primer Sequence (5′ to 3′, underlined sequences are designed
restriction sites)
Description Reference
pr31 GGTGAGCTCTATTCTTTATTGCCGATTATC For icd insertional mutant, forward, SacI This study
pr32 AAATCTAGAGTAAGTCGCTTTAATCGCTTC For icd insertional mutant, reverse, XbaI This study
pr50 AAAGAGCTCGTGATCCAGATGTCGATGCTA For sucA insertional mutant, forward, SacI This study
pr51 GGTTCTAGAGTTCAGTGTCGATAATGTGCA For sucA insertional mutant, reverse, XbaI This study
pr52 AAAGAGCTCGGTCGGATTAGTACAGCGAAG For sucC insertional mutant, forward, SacI This study
pr53 GGTTCTAGACTTTTTCAATTTCCACGCCGC For sucC insertional mutant, reverse, XbaI This study
pr54 AAAGAGCTCATGTTCGTTGCGGTCGGAATT For sdhC insertional mutant, forward, SacI This study
pr55 GGTTCTAGATCCAACTCTTCAAAGTGGCCC For sdhC insertional mutant, reverse, XbaI This study
pr56 GGTGAGCTCTCCTTGCACCATATTGATATG For fumA insertional mutant, forward, SacI This study
pr57 GGGTCTAGAAGGCTTATCATCGAGAAGAGAG For fumA insertional mutant, reverse, XbaI This study
pr29 GGTGAGCTCATGCCAGCGTTAACATTAAAC For mdh insertional mutant, forward, SacI This study
pr30 AAATCTAGAGCTGTATGACATCGCACCGGT For mdh insertional mutant, reverse, XbaI This study
pr33 AAAGAGCTCGCGGCGTGAGACTAAGGCATC For cra insertional mutant, forward, SacI This study
pr34 AAATCTAGACAATGGCAAAGCGCAGAAGTA For cra insertional mutant, reverse, XbaI This study
vah1 F RT GTTTGGTATGGAACACCGCTCAAG For vah1 qRT-PCR, forward This study
vah1 R RT GGCTCAACCTCTCCTTGTAACCAA For vah1 qRT-PCR, reverse This study
plp F RT CAGACGACCACCAGTAACCACTAA For plp qRT-PCR, forward [8]
plp R RT GCAATCATGATGACCCAGCAACAG For plp qRT-PCR, reverse [8]
Pm111 GGAAATTATTCCGCCGACGATGGA For rtxA qRT-PCR, forward [7]
Pm112 GCCGATACCGTATCGTTACCTGAA For rtxA qRT-PCR, reverse [7]
Mou et al. BMC Microbiology  (2017) 17:217 Page 4 of 14
frdABCD fumA, and mdh (Fig. 1 and Table 3). While
this set of genes allows for a fully functional TCA
cycle, none of the strains have a fumC gene, which
encodes the aerobic fumarate class II hydratase. All
strains also lack the anaerobic fumarate hydratase
(fumB) gene. Additionally, all strains possessed cra,
which encodes the repressor of fructose metabolism
in S. enterica [22]. The V. anguillarum M93Sm se-
quences for the icd, sucA, sucC, sdhC, fumA, mdh,
and cra genes were used to create insertional muta-
tions in V. anguillarum M93Sm. The seven mutant
strains and the one restored strain listed in Table 1
were constructed using the primers listed in Table 2
as described in the Methods.
icd mutant is highly attenuated for virulence against
rainbow trout
The virulence of the seven V. anguillarum metabolism
mutants were tested on rainbow trout and compared to
wild type M93Sm in order to determine if mutations in
metabolism could affect pathogenesis. Groups of five fish
were infected by IP-injection (as described in the
Methods) with either the wild type (M93Sm), icd mutant
(XM420), sucA mutant (XM440), sucC mutant (XM450),
sdhC mutant (XM460), fumA mutant (XM470), mdh
mutant (XM410) or cra mutant (XM430) in NSS at a
dosage of ~2 × 105 CFU per fish. Injection with NSS only
served as a negative control (Mock). During the 14-day
observation window, 40% of M93Sm infected fish
Fig. 1 Embden-Meyerhoff-Parnas Pathway, TCA cycle, and metabolism of fructose. The arrows indicate the physiological directions of the
reactions. The gene symbols of the enzyme for each reaction are listed beside the reaction. Boxed genes indicate the genes that were mutated
in this study (Table 1)
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survived. Fish infected with the sucA mutant, sdhC mu-
tant or icd mutant had a higher survival percentage than
M93Sm (50% for sucA mutant, 80% for sdhC mutant,
and 100% for icd mutant); however, only the difference
between the icd mutant and M93Sm was statistically
significant (p = 0.037) (Fig. 2a). The experiment was re-
peated using a two-fold higher dose (~4 × 105 CFU per
fish) of M93Sm and the three mutant strains (icd
mutant, sucA mutant and sdhC mutant) that exhibited
attenuated virulence in the previous experiment. At this
dose, only 20% of M93Sm-infected fish survived. Only
the icd mutant-infected fish had a statically significant
higher survival percentage (100%) compared to M93Sm
(p = 0.0153) (Fig. 2b). The data indicate the icd mutant is
avirulent in these experimental conditions.
Further, we tested the virulence of M93Sm and the
icd mutant by another infection route. Groups of 10
fish were infected by immersion as described in the
Methods with M93Sm or icd mutant in 1.5% salt so-
lution at a dose of ~4 × 106 CFU/ml, or just immersed
in a 1.5% salt solution without V. anguillarum as a
negative control (Mock). During the 14-day observa-
tion window, there was a statistically significant dif-
ference (p = 0.007) between the survival of M93Sm
infected fish (30%) and icd mutant infected fish (90%)
(Fig. 3). Taken together, the IP infection data and the
immersion infection data demonstrate that the icd
mutant is highly attenuated for infection in rainbow
trout.
Pre-treatment by immersion with the icd mutant
protected rainbow trout from the subsequent challenge
of V. anguillarum M93Sm
Fish previously challenged by immersion with the icd
mutant were subsequently challenged with the wild type
M93Sm strain to test if the icd mutant was immuno-
genic. Six weeks after the initial infection, a group of five
fish that survived the initial infection with the icd mu-
tant (labeled as “treated with the icd mutant” in Fig. 4)
and a group of five “untreated” fish were infected via
immersion with M93Sm at a dose of ~4 × 106 CFU/ml
and were observed for 14 days. By day 2 all fish in the
untreated group died. All fish in the group treated with
the icd mutant survived the 14-day observation period.
The difference between the two experimental groups
was statistically significant (p = 0.008). The results indi-
cate that the icd mutant is immunogenic and protective
against wild type infection when administered by
immersion.
All mutants exhibited either same or higher expression
levels of the three hemolysin genes compared to wild
type
Vah1, RtxA, and Plp are the three hemolysins found
in M93Sm and are responsible for the hemolytic/cyto-
lytic activity against fish erythrocytes, leukocyte and
epithelial cells [7, 9, 11] and unpublished data]. We
tested the expression of vah1, rtxA and plp during
exponential phase to determine whether mutations in
metabolism could affect the expression of these
hemolysin genes. Data indicate that in all mutants ex-
cept the icd mutant, expression of vah1 and plp were
up regulated by 1.49–16.15-fold compared to M93Sm
with most of the changes being significant (Fig. 5). In
the icd mutant, expression of plp was up regulated by
1.76-fold while the expression of vah1 was slightly
decreased (to 49% of WT), neither of which was a
significant change from M93Sm (Fig. 5). Plp is the
most efficient hemolysin against fish erythrocytes [11].
TCA cycle mutants with an increased expression of
plp also demonstrated an increased zone of hemolysis
on 5% fish blood agar plates (Additional file 1: Figure
S1). There was no change in the zone of hemolysis
for the icd mutant. Expression of rtxA in all mutants
was not significantly different from M93Sm (Fig. 5).
Taken together, all metabolism mutants have the same
or higher expression levels of hemolysin genes com-
pared to the wild type.
Table 3 Metabolism genes examined in this study
Gene or
operon
Product Present in sequenced
V. anguillarum strains a
gltA Type II citrate synthase Yes
acnB Aconitate hydratase B Yes
icd Isocitrate dehydrogenase Yes
sucAB 2-oxoglutarate dehydrogenase
(E1 component, E2 component)
Yes
sucCD Succinyl-CoA synthetase
(beta subunit, alpha subunit)
Yes
sdhCDAB Succinate dehydrogenase
(cytochrome b556 subunit,
membrane anchor subunit,
flavoprotein subunit,
iron-sulfur protein)
Yes
frdABCD Fumarate reductase
(flavoprotein subunit,
iron-sulfur subunit, anchor
subunit, anchor subunit)
Yes
fumAC Aerobic fumarate hydratase
(class I, class II)
fumA: Yes; fumC:
not found
fumB Anaerobic fumarate hydratase
(class I)
Not found
mdh Malate dehydrogenase Yes
cra Fructose repressor protein Yes
a V. anguillarum strains: M93Sm, 775, 96F, M3, NB10, RV22, 90-11-286
Mou et al. BMC Microbiology  (2017) 17:217 Page 6 of 14
icd mutant exhibited significant lower cell density limit
than wild type in two forms of rich media
Figure 6 shows the typical growth curves for the wild
type V. anguillarum M93Sm and the seven metabolism
mutants in LB20 broth. In these growth conditions,
M93Sm, the icd mutant, and the cra mutant exhibited
classic bacterial growth curves with a lag phase, an
exponential phase and a stationary phase. The sucA,
sucC, sdhC, fumA and mdh mutants all exhibited a
two-stage growth curve, with each stage consisting of
a lag phase and an exponential phase. The exponen-
tial phase in the first growth stage was named expo-
nential phase I and the exponential phase in the
second growth stage was named exponential phase II.
The generation times of the exponential phases of all
mutants were longer than for M93Sm (Table 4). The final
cell density (measured by OD600) of the icd mutant after
23 h was the lowest among all strains. Similarly, after 24 h
of growth in LB20 the final cell density (CFU/ml) of
the icd mutant was 47% that of M93Sm (Table 5)
and the difference is significant (p = 0.011). M93Sm
and the icd mutant were grown in NSS supple-
mented with 200 μg protein/ml of fish gastrointes-
tinal mucus (NSSM) to better replicate conditions
within a host. After 24 h of growth in NSSM the
final cell density of the icd mutant was only ~31% of
that for M93Sm (Table 5) and the difference is sig-
nificant (p = 0.007).
a
b
Fig. 2 Percent survival of rainbow trout IP injected with V. anguillarum wild type (M93Sm) and various mutant strains at a dosage of a 2 × 105
CFU/fish and b 4 × 105 CFU/fish. Negative control groups of fish (Mock) were injected with sterile NSS. Five fish were used for each treatment.
(One fish treated with the sucA mutant died, but not from vibriosis and no V. anguillarum were recovered, so only four fish were counted).
*Statistically significant difference compared to M93Sm (p < 0.05)
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Growth in LB20 supplemented with 118 mM glutamate
restores growth of the icd mutant to wild type levels
The icd mutant is unable convert isocitrate into α-
ketoglutarate, the immediate precursor of glutamate.
Consequently, the icd mutant was only able to grow in
3 M + 0.15% glucose with the addition of glutamate
(Fig. 7a). Glutamate was added to LB20 to determine if
the icd mutant final cell density would increase. Fig-
ure 7b shows the typical growth curves of M93Sm and
the icd mutant in LB20 with (solid lines) and without
(dashed lines) the addition of 118 mM of glutamate.
After 24 h, M93Sm and the icd mutant grew to similar
final cell densities when LB20 was supplemented with
118 mM glutamate. Additionally, Fig. 7c demonstrate
that decreasing the amount of glutamate (from 118 mM
to 2.95 mM) added to LB20 decreases the final cell dens-
ity of the icd mutant, but not M93Sm, after 24 h of
growth. The final cell density of the icd mutant was not
restored to a wild type level when LB20 was supplemented
with glucose, succinate (Additional file 2: Figure S2) or glu-
conate (Fig. 7c).
Resolving the merodiploid in the icd mutant restores
growth and pathogenicity
A revertant to the wild type icd gene was selected to
demonstrate that the icd mutant (XM420, a merodiploid
with an insertion in the icd gene) contained no add-
itional mutations that could be causing the loss of
pathogenicity and decreased cell density. Initially, at-
tempts were made to complement the icd mutant in
trans by cloning icd and its native promoter into the
pSUP203 vector; however, all pSUP203-icd vectors
isolated from E. coli SM10 contained single nucleotide
substitutions that resulted in amino acid changes in icd
that inactivated isocitrate dehydrogenase (data not
shown). Since the icd mutant is unable to grow on 3M
+ glucose, icd mutants that spontaneously resolved the
merodiploid were isolated on 3M + glucose agar plates
as described in the Methods. The reversion rate of the
icd mutant to a wild type phenotype grown in LB20
overnight was calculated to be 1 out of 1.6 × 1010 cells.
Additional file 3: Figure S3 shows the typical growth
curves for M93Sm, the icd mutant and the restored icd
strain in LB20 and 3M+ 0.15% glucose. M93Sm and the
restored icd strain were able to grow in 3M+ 0.15% glu-
cose unlike the icd mutant (Additional file 3: Figure S3A).
Additionally, when the strains were grown in LB20 the
final cell density returned to wild type levels when icd was
restored (Additional file 3: Figure S3B). To determine if
restoring icd restores pathogenicity, juvenile rainbow trout
were challenged via immersion with M93Sm, the icd mu-
tant and the restored icd strain at a dose of between 4 ×
106 and 8 × 106 CFU/ml. After day 8, 26% (5/19) of the
M93Sm challenged fish, 40% (6/15) of the restored icd
challenged fish and 95% (19/20) of the icd mutant chal-
lenged fish survived (Fig. 8). There was no statistically sig-
nificant difference between M93Sm and the restored icd
strain ( p= 0.50). Again, there was a statistically significant
difference between M93Sm and the icd mutant (p <
0.00004). The results indicate that when the merodiploid
present in the icd mutant is resolved, wild type levels of
growth in 3M+ 0.15% glucose and LB20 and pathogen-
icity against juvenile rainbow trout is returned.
Discussion
The tricarboxylic acid (TCA) cycle is involved in the
generation of energy through the oxidation of acetate.
TCA intermediates serve as precursor metabolites for
Fig. 3 Percent survival of rainbow trout infected by immersion with
V. anguillarum strains M93Sm (wild type) or XM420 (icd) at a dose of
4 × 106 CFU/ml. A negative control group of fish (Mock) was
immersed in sterile NSS. Ten fish were used for each treatment.
*Statistically significant difference compared to M93Sm (p < 0.05)
Fig. 4 Percent survival of immersion vaccinated rainbow trout.
Rainbow trout were sham vaccinated with NSS (labeled as
“untreated”) or immersed vaccinated with the icd mutant (Labeled
as “treated with icd”) and challenged with wild type V. anguillarum
M93Sm (4 × 106 CFU/ml). Five fish were used for each treatment.
*Statistically significant difference compared to M93Sm (p < 0.05)
Mou et al. BMC Microbiology  (2017) 17:217 Page 8 of 14
the synthesis of amino acids and peptidoglycan. The
M93Sm genome along with the published genomes of V.
anguillarum strains 775, 96F, M3, NB10, RV22, 90-11-
286 were examined for TCA cycle enzymes and the fol-
lowing genes were found: gltA, acnB, icd, sucAB, sucCD,
sdhCDAB, frdABCD, fumA, and mdh (Fig. 1 and Table 3).
Additionally, cra, which encodes the repressor of
fructose metabolism in S. enterica and E. coli and has
previously been shown to be essential for S. enterica
virulence, is present in the V. anguillarum genomes [22].
When in a nutrient limited environment, bacteria
must be able to synthesize any essential metabolites that
are not freely available in order to grow. Previous studies
have shown that mutations in central metabolism genes
result in attenuation of virulence in several intracellular
pathogens including S. enterica, uropathogenic E. coli
(UPEC), M. tuberculosis and E. ictaluri [17–19, 21, 23–
26]. These observations suggest that central metabolism
is necessary for these intracellular pathogens to function
inside the nutrient-limited environment of the phago-
some; however, V. anguillarum is not an intracellular
pathogen. While some studies have suggested that V.
anguillarum can survive internally in fish epithelial cells
and CHSE cells (derived from pooled embryonic cells
from Oncorhynchus tshawytscha), more recent studies
have demonstrated that V. anguillarum actively evades
phagocytosis by fish epithelial cells and cannot survive
for 24 h in macrophages [35–38]. In this study, fish were
infected with V. anguillarum strains by either of two
methods: intraperitoneal injection or immersion with
both methods resulting in a similar percent survival
when fish were challenged with M93Sm (20% for injec-
tion, see Fig. 2a and b; 0%~30% for immersion, see
Fig. 3). Only the icd mutant had a statistically significant
higher level of survival compared to the wild type, 100%
for IP injection (Fig. 2a and b) and 90% for immersion
(Fig. 3). It is not thought that reversion of the merodi-
ploid to a wild type phenotype caused the other
Fig. 5 Relative expression of vah1, plp, rtxA determined by qRT-PCR analysis of V. anguillarum wild-type (M93Sm) and various TCA mutants during
logarithmic (Log)-phase growth. The data presented are representative of two independent experiments. Each value is the average for three
replicates. Between marked strains and M93Sm: * p < 0.05 and *** p < 0.001. Error bars represent 1 standard deviation
Fig. 6 Growth curves of various V. anguillarum strains grown in LB20 at 27 °C with shaking (200 rpm). At various time points after inoculation
samples were taken for determination of optical density at 600 nm (OD600). The data are from one representative experiment
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metabolism mutants to be virulent because chloram-
phenicol resistant colonies were isolated from the organs
of dead fish. IP injection bypasses the need for invasion.
No mortalities resulted from IP injection with the icd
mutant indicating that icd is required for V. anguillarum
persistence and growth in fish tissues. Rainbow trout in-
fected with the icd mutant via immersion and subse-
quently challenged with the M93Sm wild type showed
100% survival (Fig. 4) demonstrating that the icd mutant
had immunoprotective effects and elicited an adaptive
immune response. Moreover, as a proof of concept, the
data suggest that an icd deletion mutant could be the
basis for a live attenuated vaccine against V. anguillarum
infection.
Our observation that a knockout of the icd gene re-
sults in attenuation of virulence raises the question of
whether expression of required virulence genes is signifi-
cantly reduced in the mutant and, therefore, results in
attenuation. We previously identified and characterized
three hemolysin/cytolysin genes and their encoded pro-
teins secreted by V. anguillarum: plp, vah1 and rtxA [7,
9, 11]. While mutations in plp and vah1 have modest ef-
fects on virulence against fish epithelial cells and fish, a
knockout mutation in rtxA is avirulent in fish [7, 9, 11].
All metabolism mutants exhibited no significant declines
in the expression of three hemolysins (Fig. 5) and most
of the mutants exhibited increased expression. Accord-
ingly, the icd mutant is not attenuated by the lack of he-
molysin production because the decrease in rtxA and
vah1 expression was not significant; however, future
studies could examine the expression of other virulence
factors. It is unclear why expression of plp and vah1 is
increased in the metabolism mutants. Minato et al. [39]
demonstrated the accumulation of acetyl-CoA in Vibrio
cholerae central metabolism mutants resulted in an in-
creased expression of its virulence gene activator ToxT.
It is possible that accumulation or depletion of certain
metabolites in V. anguillarum could increase hemolysin/
cytolysin expression. Expression of hlyU, the positive
regulator of the both the vah1 plp gene cluster and the
rtxA gene cluster, was examined and shown to be up-
regulated in the sucA and mdh mutants (data not
shown) [40]. However, the increased expression of hlyU
may not be the sole explanation for the increased ex-
pression of plp and vah1 because an increase in expres-
sion of rtxA should have also occurred.
The growth rate and final cell density was determined
for all metabolism mutants grown in LB20 for 24 h. The
slowest growing mutant, fumA, was as virulent as the
wild type while the mutant with the lowest final cell
density, icd, was attenuated suggesting that decreased
final cell density results in a loss of pathogenicity against
rainbow trout (Figs. 2, 6, Tables 4 and 5). When the mu-
tation in icd was resolved, the restored icd strain demon-
strated the wild type phenotype for both growth and
pathogenicity (Additional file 3: Figure S3A and B and
Fig. 8). While it is possible that the insertional mutation
affected the expression of the two genes flanking icd
(ribosomal large subunit pseudouridine synthase E (Ac-
cession number: WP_017043910.1) and cold shock do-
main protein CspD (Accession number:
WP_013857087.1)), it is unlikely as neither gene is part
of an operon that includes icd. Since isocitrate dehydro-
genase catalyzes the formation of α-ketoglutarate (the
immediate precursor of glutamate) from isocitrate, the
icd mutant is auxotrophic for glutamate (Fig. 7a). Our
data demonstrate that the icd mutant stops growing
once exogenous glutamate or its derivatives are
exhausted (Fig. 7b and c). The data also demonstrate the
decreased growth yield was not do to a reduction of
ATP production as addition of gluconate or succinate
did not restore growth to a wild type cell density. It is
interesting that the only other auxotrophic mutant,
sucA, grows to a wild type cell density in LB20 and is as
virulent as the wild type considering it cannot synthesize
succinyl-CoA, a metabolite needed for the synthesis of
lysine, methionine and diaminopimelic acid. Presumably,
succinyl-CoA or its derivatives are not limiting in LB20
or in fish tissues. Furthermore, this also suggests that
the icd mutant is primarily starved for glutamate and
would not need to synthesize succinyl-CoA by metabol-
izing glutamate to α-ketoglutarate. We hypothesize that
during infection the icd mutant is unable to obtain
enough α-ketoglutarate derivatives to grow to a wild
type cell density and, therefore, cannot reach a cell
Table 4 Generation times of various V. anguillarum strains
grown in LB20a
Strain Exponential Phase I
(Minutes)
Exponential Phase II
(Minutes)
M93Sm 44.00 NA
icd 54.95 NA
sucA 64.32 98.52
sucC 52.42 99.57
sdhC 61.19 101.70
fumA 73.55 89.38
mdh 67.11 115.28
cra 58.59 NA
NA not applicable
aValues calculated from data presented in Fig. 6 during exponential growth
Table 5 Final cell density (CFU/ml) of various V. anguillarum
cultures grown for 24 h
Strain CFU/ml in LB20 CFU/ml in NSSM (200 μg/ml)
M93Sm 3.4 × 109 (±0.3 × 109) 4.2 × 109 (±0.7 × 109)
icd 1.6 × 109 (±0.02 × 109)* 1.3 × 109(±0.3 × 109)*
*Statistically significant difference compared to M93Sm (p < 0.05)
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density necessary for a successful systemic infection. In
support, it has previously been demonstrated that a V.
anguillarum M93Sm mugA mutant that was unable to
grow in salmon intestinal mucus was avirulent against
Atlantic salmon [41]. Additionally, when V. anguillarum
775 was cured of its plasmid-encoded siderophore, the
mutant was unable to sequester iron and exhibited de-
creased virulence [42, 43].
M93Sm is an O2α serotype and the presumed infec-
tion route is through the gastrointestinal tract as no nec-
rotic skin lesions have ever been observed with this
strain (unpublished data). The in vitro growth experi-
ment (Table 5) suggests that there are not enough α-
ketoglutarate derivatives in intestinal mucus to support
the growth of the icd mutant to a wild type cell density
even though it is the metabolite with the second highest
concentration (3.03 mM) in rainbow trout mucus [44].
It should be noted that for in vitro growth experiments
a
b
c
Fig. 8 Percent survival of rainbow trout immersed with various V.
anguillarum strains at a dosage of 4 × 106 to 7 × 106 CFU/ml. Five
fish were used for the uninfected (mock) group. Fifteen fish were
treated with the restored icd strain. Nineteen fish were treated with
M93Sm and twenty fish were treated with the icd mutant.
*Statistically significant difference compared to M93Sm (p < 0.01)
Fig. 7 Growth of V. anguillarum WT (M93Sm) and the icd mutant
under various conditions. a Final cell densities (OD600) of V.
anguillarum strains after 24 h of growth in 3M plus 0.15% glucose
supplemented with or without 5.9 mM glutamate. b Growth curves
of V. anguillarum M93Sm (black) and the icd mutant (blue) in LB20
(dashed lines) or LB20 supplemented with 118 mM glutamate (solid
lines). Statistical analysis was based on data at 24 h. c Final cell
densities (OD600) of V. anguillarum M93Sm and icd mutant strains
grown in LB20 supplemented with decreasing amounts of
glutamate. In each experiment cells grown overnight in LB20 were
washed in NSS and used to inoculate the appropriate media.
Cultures were incubated at 27 °C in a shaking water bath (200 rpm)
and at various time points after inoculation samples were taken for
determination of optical density at 600 nm (OD600). Different letters
indicate statistical significance among groups (p < 0.05). Error bars
represent 1 standard deviation
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the concentrations of glutamate and glutamine in the
mucus are not known and the growth conditions repre-
sent an ideal environment for growth; V. anguillarum
does not have to evade the fish immune system or com-
pete with commensal bacteria and it is not expected that
the icd mutant will grow to the cell density shown in the
in vitro growth experiments in the fish. As demonstrated
by Muroga et al., [45] V. anguillarum found in the
spleen and intestine of moribund fish challenged via
immersion only reached a cell density of 4.0 × 108 CFU/g
and 2.5 × 107 CFU/g respectively. Altinok et al. [46]
showed a V. anguillarum succinate dehydrogenase mu-
tant was avirulent against rainbow trout when injected
at a dose at 105 CFU. Similar to our results, the authors
showed that the succinate dehydrogenase mutant grew
to a cell density slightly lower than the wild type at 12 h;
however, the authors failed to show the growth yield at
24 h. Further, the authors did not create a complement
strain to demonstrate that the loss of virulence was
solely do to mutating sdhB. Most importantly, the ATCC
has redesignated their strain as a Pseudomonas species.
Conclusions
Seven V. anguillarum metabolism mutants were cre-
ated and examined for pathogenicity against juvenile
rainbow trout, hemolysin/cytolysin expression and
growth in rich media. Of the central metabolism mu-
tants, only the icd mutant showed strong attenuation
in virulence, which did not result from a decrease in
virulence factor expression. In addition, only the icd
mutant had a final cell density that was lower than
the wild type, which resulted from the inability to
synthesize α-ketoglutarate and downstream metabo-
lites. Taken together, the data suggest that during in-
fection, if V. anguillarum is unable to synthesize
essential molecules (e.g. α-ketoglutarate/2-oxogluta-
rate) and when those molecules or their derivatives
(e.g. glutamate, glutamine) become limiting in the
host, V. anguillarum will be unable to grow to a
density necessary to sustain a systemic infection of
the host.
Additional files
Additional file 1: Figure S1. Hemolytic activity of various V. anguillarum
strains grown on fish blood agar. Colonies grown overnight on LB20 plates
were tooth picked onto LB20 + 5% trout blood agar plates. The diameter of
the zones of hemolysis were measured after 7 h and 23 h of growth at 27 °
C. Between marked strains and M93Sm: * p < 0.05 and ** p < 0.01. Error bars
represent 1 standard deviation (PDF 146 kb)
Additional file 2: Figure S2. Final cell densities (OD600) of V.
anguillarum WT (M93Sm) and the icd mutant after 24 h of growth in
LB20 supplemented with or without 118 mM glucose and 118 mM
succinate. Error bars represent 1 standard deviation (PDF 145 kb)
Additional file 3: Figure S3. Growth curves of V. anguillarum strains
M93Sm (WT), the icd mutant and the restored icd strain grown in A) 3 M
+ 0.15% glucose and B) LB20. In each experiment cells grown overnight
in LB20 at 27 °C were washed in NSS and used to inoculate the
appropriate media. Cultures were incubated at 27 °C in a shaking water
bath (200 rpm) and at various times after inoculation, samples were taken
for determination of optical density at 600 nm (OD600). Different letters
indicate statistical significance among groups (p < 0.05). Statistical analysis
was based on data of stationary phase cultures (>12 h) (PDF 142 kb)
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